131 related articles for article (PubMed ID: 8956350)
1. The efficacy of L-methadone and racemic methadone in substitution treatment for opiate addicts--a double-blind comparison.
Scherbaum N; Finkbeiner T; Leifert K; Gastpar M
Pharmacopsychiatry; 1996 Nov; 29(6):212-5. PubMed ID: 8956350
[TBL] [Abstract][Full Text] [Related]
2. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
[TBL] [Abstract][Full Text] [Related]
3. The effects of racemic D,L-methadone and L-methadone in substituted patients--a randomized controlled study.
Verthein U; Ullmann R; Lachmann A; Düring A; Koch B; Meyer-Thompson HG; Schmidt R; Reimer J; Haasen C
Drug Alcohol Depend; 2005 Nov; 80(2):267-71. PubMed ID: 15916866
[TBL] [Abstract][Full Text] [Related]
4. Feasability and safety of transfer from racemic methadone to (R)-methadone in primary care: clinical results from an open study.
Soyka M; Zingg C
World J Biol Psychiatry; 2009; 10(3):217-24. PubMed ID: 19629858
[TBL] [Abstract][Full Text] [Related]
5. Prescribing methadone for the opiate addict: a problem of dosage conversion.
Johns AR; Gossop M
Drug Alcohol Depend; 1985 Sep; 16(1):61-6. PubMed ID: 4064909
[TBL] [Abstract][Full Text] [Related]
6. Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.
Umbricht A; Hoover DR; Tucker MJ; Leslie JM; Chaisson RE; Preston KL
Drug Alcohol Depend; 2003 Apr; 69(3):263-72. PubMed ID: 12633912
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of buspirone in the treatment of opioid withdrawal.
Buydens-Branchey L; Branchey M; Reel-Brander C
J Clin Psychopharmacol; 2005 Jun; 25(3):230-6. PubMed ID: 15876901
[TBL] [Abstract][Full Text] [Related]
8. Craving and drug reward: a comparison of methadone and clonidine in detoxifying opiate addicts.
Dawe S; Gray JA
Drug Alcohol Depend; 1995 Oct; 39(3):207-12. PubMed ID: 8556969
[TBL] [Abstract][Full Text] [Related]
9. Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal.
Carnwath T; Hardman J
Drug Alcohol Depend; 1998 May; 50(3):251-4. PubMed ID: 9649979
[TBL] [Abstract][Full Text] [Related]
10. Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts.
Hensel M; Kox WJ
Acta Anaesthesiol Scand; 2000 Mar; 44(3):326-33. PubMed ID: 10714849
[TBL] [Abstract][Full Text] [Related]
11. Comparison of buprenorphine and methadone maintenance in opiate addicts.
Eder H; Fischer G; Gombas W; Jagsch R; Stühlinger G; Kasper S
Eur Addict Res; 1998; 4 Suppl 1():3-7. PubMed ID: 9767199
[TBL] [Abstract][Full Text] [Related]
12. Effects of buspirone in withdrawal from opiates.
Rose JS; Branchey M; Wallach L; Buydens-Branchey L
Am J Addict; 2003; 12(3):253-9. PubMed ID: 12851021
[TBL] [Abstract][Full Text] [Related]
13. Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.
Bearn J; Gossop M; Strang J
Drug Alcohol Depend; 1998 May; 50(3):227-32. PubMed ID: 9649976
[TBL] [Abstract][Full Text] [Related]
14. The prescribing of methadone and other opioids to addicts: national survey of GPs in England and Wales.
Strang J; Sheridan J; Hunt C; Kerr B; Gerada C; Pringle M
Br J Gen Pract; 2005 Jun; 55(515):444-51. PubMed ID: 15970068
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
[TBL] [Abstract][Full Text] [Related]
16. Sublingual buprenorphine and methadone maintenance treatment: a three-year follow-up of quality of life assessment.
Giacomuzzi SM; Ertl M; Kemmler G; Riemer Y; Vigl A
ScientificWorldJournal; 2005 May; 5():452-68. PubMed ID: 15925962
[TBL] [Abstract][Full Text] [Related]
17. Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study.
Soyka M; Zingg C; Koller G; Kuefner H
Int J Neuropsychopharmacol; 2008 Aug; 11(5):641-53. PubMed ID: 18205978
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine versus methadone maintenance for the treatment of opioid dependence.
Fischer G; Gombas W; Eder H; Jagsch R; Peternell A; Stühlinger G; Pezawas L; Aschauer HN; Kasper S
Addiction; 1999 Sep; 94(9):1337-47. PubMed ID: 10615719
[TBL] [Abstract][Full Text] [Related]
19. Appropriateness of methadone maintenance treatment for opiate addiction: evaluation by an expert panel.
Vader JP; Hämmig R; Besson J; Eastus C; Eggenberger C; Burnand B
Soz Praventivmed; 2003; 48 Suppl 1():S1-14. PubMed ID: 12891872
[TBL] [Abstract][Full Text] [Related]
20. [Buprenorphine or methadone for detoxification of young opioid addicts?].
Ebner R; Schreiber W; Zierer C
Psychiatr Prax; 2004 Nov; 31 Suppl 1():S108-10. PubMed ID: 15570521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
